Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

55results about How to "Administration of has been hampered" patented technology

Dosage determination supporting device, injector, and health management supporting system

A dosage determination supporting apparatus, which is able to precisely determine a dosage in accordance with the health condition of a user, is provided with: a sensor (28) for measuring the blood sugar level obtained from the blood of the user; a memory (48) for storing an operation table showing a correspondence between the blood sugar level and the amount of insulin; a CPU (50) for calculating the amount of insulin corresponding to the blood sugar level, with reference to the operation table stored in the memory (48); a displaying unit (34) for displaying the amount of insulin; and a voice processing unit (52) for performing the voice processing on the amount of insulin and outputting the voice through a speaker (32).
Owner:PANASONIC CORP

Method of generating an implementation of reusable parts from containers of a workflow process-model

Method for automatically generating an implementation of input and output container reusable parts for a process model managed and executed by at least one computer system. The method of generating uses the specification of a process model extended by specifications associating the process model to a reusable part environment outside the workflow process environment and generates an implementation of said input and output containers as reusable parts residing within said reusable parts environment. The method of generating comprises an analysis of the specifications of said process model. Based on this analysis the method generates the associated input container reusable parts and associated output container reusable parts as implementations of said input and output containers.
Owner:IBM CORP

Factor

Provided is a method of producing neurite outgrowth and / or development using RARĪ²2 and / or an agonist thereof.
Owner:MADEN MALCOLM +1

Computational pathology systems and methods for early-stage cancer prognosis

ActiveUS20170270666A1Reduce computing costInformed choiceImage enhancementImage analysisComputational pathologyLow risk group
The subject disclosure presents systems and computer-implemented methods for providing reliable risk stratification for early-stage cancer patients by predicting a recurrence risk of the patient and to categorize the patient into a high or low risk group. A series of slides depicting serial sections of cancerous tissue are automatically analyzed by a digital pathology system, a score for the sections is calculated, and a Cox proportional hazards regression model is used to stratify the patient into a low or high risk group. The Cox proportional hazards regression model may be used to determine a whole-slide scoring algorithm based on training data comprising survival data for a plurality of patients and their respective tissue sections. The coefficients may differ based on different types of image analysis operations applied to either whole-tumor regions or specified regions within a slide.
Owner:VENTANA MEDICAL SYST INC

System and method for multiple injection procedures on heart vessels

InactiveUS8082018B2Readily and accurately permittedFlexible and user friendlyElectrotherapyElectrocardiographyMultiple injectionOperation mode
An angiographic injector system and a method of controllably delivering medical fluid to a patient from an angiographic injector system are disclosed. A multiple processor control system is used to actively control the injection process and to monitor sensed functions of the system. The multiple processors provide dual redundancy safety circuits for critical control functions such as syringe motor drive speed and current. A motor / servo-amplifier nested control function is also disclosed. A unique method and apparatus are disclosed for establishing injection parameter default values just prior to an injection procedure that are based on physiological values of the patient to be treated. The injector system uses an interactive display panel that presents sequenced set-up screens to the user and which enables the user to select injection procedures, parameters and other modes of operation directly through the interactive panel.
Owner:ACIST MEDICAL SYST

Angiographic injector system and method of use

InactiveUS7128729B2Readily and accurately permittedFlexible and user friendlyElectrocardiographyInfusion syringesOperation modeEngineering
An angiographic injector system and a method of controllably delivering medical fluid to a patient from an angiographic injector system are disclosed. A multiple processor control system is used to actively control the injection process and to monitor sensed functions of the system. The multiple processors provide dual redundancy safety circuits for critical control functions such as syringe motor drive speed and current. A motor / servo-amplifier nested control function is also disclosed. A unique method and apparatus are disclosed for establishing injection parameter default values just prior to an injection procedure that are based on physiological values of the patient to be treated. The injector system uses an interactive display panel that presents sequenced set-up screens to the user and which enables the user to select injection procedures, parameters and other modes of operation directly through the interactive panel.
Owner:ACIST MEDICAL SYST

Systems and methods for monitoring the use of medications

Systems and methods for monitoring the use of a fluid over the lifecycle of the fluid, said systems including a plurality of fluid identification stations, each station having one or more sensors to detect and identify a parameter of a fluid, wherein a each station is operably interconnected thereby permitting each station to access and verify the identity of a fluid as determined by each independent fluid identification station.
Owner:BECTON DICKINSON & CO

Device, system, kit or method for collecting effluent from an individual

The present invention relates to a device, method, system and kit for receiving effluent from an individual. In an alternative embodiment, the present invention is directed to a device, method, system and kit for collecting effluent from an individual during a medical or diagnostic procedure including but not limited to, imaging or viewing one or more sections of an individual's gastrointestinal tract. In another alternative embodiment, the effluent is collected in a hollow area in order to prevent the effluent form contaminating a component, device or apparatus used in connection with the medical or diagnostic procedure.
Owner:BRACCO DIAGNOSTICS

Monitoring system for a medical liquid dispensing device

The present invention is concerned with monitoring systems (1) for medical liquid dispensing devices. The systems are intended for use in any medical setting wherein a medical liquid container (4), such as an infusion bag with fluid, is to be infused into a patient and are aimed at reducing the need for visual checking by nurses or other medical assistants. This is achieved by a combination of an identification unit (2), which identifies a medical liquid container and optionally the patient to be treated, a weight monitoring unit, which measures the weight of the medical liquid container when liquid is dispensed therefrom, and a processing unit (3), which processes and / or stores data that are acquired from the identification unit and the weight monitoring unit.
Owner:SPRONKEN LEON

Protector for administering medicine

A medicine assembly, and a protector that fits over at least a portion of the medicine assembly, the protector including a bar code and a locking element openable by means of a bar code reader reading the bar code, wherein when the locking element is in a locked orientation, the protector substantially prevents administration of a substance from the medicine assembly.
Owner:MEDISAFE 1 TECH

System and method for multiple injection procedures on heart vessels

InactiveUS20100204574A1Readily and accurately permittedFlexible and user friendlyElectrotherapyMedical devicesMultiple injectionEngineering
An angiographic injector system and a method of controllably delivering medical fluid to a patient from an angiographic injector system are disclosed. A multiple processor control system is used to actively control the injection process and to monitor sensed functions of the system. The multiple processors provide dual redundancy safety circuits for critical control functions such as syringe motor drive speed and current. A motor / servo-amplifier nested control function is also disclosed. A unique method and apparatus are disclosed for establishing injection parameter default values just prior to an injection procedure that are based on physiological values of the patient to be treated. The injector system uses an interactive display panel that presents sequenced set-up screens to the user and which enables the user to select injection procedures, parameters and other modes of operation directly through the interactive panel.
Owner:ACIST MEDICAL SYST

Infusion system for preventing mischanneling of multiple medicaments

Exemplary embodiments provide a multi-medicament infusion system (10) for preventing the mischanneling of medicaments. The system may include an infusion pump (12), medicament reservoirs (16A,16B), a multi-channel lumen (18), and an infusion set (20). The medicament reservoirs may be sized and shaped differently such that the medicament reservoirs can only be inserted into the infusion pump in a unique configuration. The multi-channel lumen may include connectors that mate to corresponding connectors on the infusion pump and the infusion set only in a unique configuration. Because the various parts of the multi-infusion system may only be connected in the unique configuration, the expected medicaments may be administered appropriately and channeled to the correct infusion sites.
Owner:TRUSTEES OF BOSTON UNIV

PTP for visually handicapped person

A PTP constructed so that when the PTP is divided into a section having one or a plurality of pocket portions, a person can discriminate between the top, bottom, right and left sides of this section in the planar direction and a visually handicapped person can correctly identify the direction of medicament identifying means provided on the section. The PTP includes a flexible sheet having a pocket portion containing a tablet T, and a metal foil adhered to the flexible sheet to hermetically seal the pocket portion containing the tablet T, and the PTP is dividable into sections including a plurality of pocket portions by a dividing line. An unevenness serving as medicament identifying means is provided on a top surface of a pocket portion, and arcs are respectively formed on the dividing line on the sides so that the shapes of all the divided sections become the same.
Owner:NIPRO CORP

Electro-mechanical drug delivery device

An electro-mechanical drug delivery device comprises a main body having a distal end and a proximal end. The distal end is configured to attach to a dispense interface. A separable housing that can prevent an administration of a drug by the drug delivery device, the housing configured to cover at least a portion of the distal end of the main body when the separable housing is coupled to the main body of the drug delivery device. A conduction element is provided by the main body and configured for establishing an electrical connection with an electrical connector. Establishment of the electrical connection is prevented when the housing does not cover at least a portion of the distal end of the main body. The electrical connection may be established when the housing covers at least a portion of the distal end of the main body of the drug delivery device.
Owner:SANOFI AVENTIS DEUT GMBH

Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms

ActiveUS20140163090A1Reduced neoplastic progenitor cell proliferationReduce cell proliferationPowder deliveryGenetic material ingredientsProliferative diseaseWilms' tumor
Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have Essential Thrombocythemia (ET). Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having ET.
Owner:GERON CORPORATION

FUSION GENE OF Kif5b GENE AND Ret GENE, AND METHOD FOR DETERMINING EFFECTIVENESS OF CANCER TREATMENT TARGETING FUSION GENE

In order to identify a gene that can serve as an indicator for predicting the effectiveness of a drug treatment of cancer and to provide a novel method for predicting the effectiveness of a drug treatment targeting said gene, lung adenocarcinomas were subjected to whole-transcriptome sequencing. As a result, in-frame fusion transcripts between the KIF5B gene and the RET gene were identified. The KIF5B-RET gene fusions were detected in 6 out of 319 (2%) LADC specimens from Japanese individuals and 1 out of 80 (1%) LADC specimens from U.S.A. individuals. None of the seven subjects revealed known activating mutations such as EGFR, KRAS or ALK oncogenes; thus, said gene fusions were found to be responsible mutations (driver mutations) for oncogenesis. Since said gene fusions are considered to induce constitutive activation of RET tyrosine kinase protein, it was found that treatments with RET tyrosine kinase inhibitors are effective in patients with detection of said gene fusions.
Owner:NAT CANCER CENT

High penetration compositions and their applications

ActiveUS20110269689A1High local concentrationAvoidance of systematic administrationAntibacterial agentsOrganic active ingredientsHigh concentrationMetabolite
High penetration compositions (HPC) of a parent compound, which are capable of crossing biological barriers with high penetration efficiency. The HPCs are capable of being converted to parent drugs or parent drug-related compounds such as metabolites after crossing one or more biological barriers and thus can render treatments for the conditions that the parent drugs or parent drug-related compounds can. Additionally, the HPCs are capable of reaching areas that their parent drugs or parent drug-related compounds may not be able to access or to render a sufficient concentration at the target areas HPCs of NSAIA, for example, have demonstrated indications such as treating hair loss. A HPC can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.
Owner:TECHFIELDS BIOCHEM CO LTD

Thumb ring insert for a syringe

A thumb ring insert that reduces the effective size of a syringe thumb ring thumb passage. The insert comprises a thumb aperture adapted to receive a user's thumb in a comfortable fit with the aperture eccentric from the thumb ring passage, located close to a thumb ring bottom where an end of a syringe plunger connects to the thumb ring. Thus, range of movement between aspiration and expression of the syringe is reduced as free float of the thumb in the thumb ring is effectively eliminated. With the insert aperture close to the thumb ring bottom, the expanse between the user's thumb and fingers is also reduced when aspirating. The insert further comprises a moderately pliable circumference groove about the insert that matches the syringe thumb ring receivable therein by snapping the insert into place in the thumb ring passage with groove rims being resiliently distorted in allowing the thumb ring to pass into the groove.
Owner:STADICK EVA

Systems and methods for monitoring the use of medications

Systems and methods for monitoring the use of a fluid over the lifecycle of the fluid, said systems including a plurality of fluid identification stations, each station having one or more sensors to detect and identify a parameter of a fluid, wherein a each station is operably interconnected thereby permitting each station to access and verify the identity of a fluid as determined by each independent fluid identification station.
Owner:BECTON DICKINSON & CO

Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms

Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have Essential Thrombocythemia (ET). Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having ET.
Owner:GERON CORPORATION

High penetration prodrug compositions of peptides and peptide-related compounds

The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of peptides and peptide-related compounds, which are capable of crossing biological barriers with higher penetration efficiency comparing to their parent drugs. The HPPs are capable of being converted to parent drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs / HPCs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPPs / HPCs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.
Owner:TECHFIELDS BIOCHEM CO LTD

Air tolerant implantable piston pump

An implantable infusion device includes a reservoir for housing an infusion medium and a drive mechanism having an inlet chamber, a piston and a piston channel. The inlet chamber is in fluid communication with the reservoir. The piston channel is in fluid communication with the inlet chamber, and has a distal end and a proximal end, the proximal end being closer to the inlet channel than the distal end. The piston is axially moveable within the piston channel to drive infusion medium out of the distal end of the piston channel. The clearance between the piston and the channel is sufficiently small to prevent undissolved gas in the inlet chamber from passing through the clearance. The inlet chamber may be sufficiently large to allow undissolved gas to accumulate without adversely affecting the performance of the infusion device.
Owner:MEDTRONIC INC

Diagnosis and therapy of Multiple Sclerosis

The serotonin receptor 5HT2A (5HT2aR) and membrane NADPH oxidases (NOX enzymes) are found to be a target of autoantibodies present in Multiple Sclerosis patients. The present invention refers to peptides comprised in the extracellular regions of the human 5HT2aR and / or NOXs for diagnosis and therapy of Multiple Sclerosis.
Owner:PRINDEX SRL

High penetration prodrug compositions of peptides and peptide-related compounds

The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of peptides and peptide-related compounds, which are capable of crossing biological barriers with higher penetration efficiency comparing to their parent drugs. The HPPs are capable of being converted to parent drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs / HPCs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPPs / HPCs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate.
Owner:TECHFIELDS BIOCHEM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products